Marshall Wace North America’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Hold |
0
| – | – | – | 1918 |
|
|
2020
Q4 | – | Sell |
-1,862,165
| Closed | -$4.19M | – | 1714 |
|
|
2020
Q3 | $4.19M | Sell |
1,862,165
-4,092,791
| -69% | -$9.21M | 0.03% | 430 |
|
|
2020
Q2 | $21.3M | Buy |
5,954,956
+880,440
| +17% | +$3.15M | 0.14% | 165 |
|
|
2020
Q1 | $19.3M | Buy |
5,074,516
+1,685,361
| +50% | +$6.4M | 0.15% | 157 |
|
|
2019
Q4 | $10.2M | Buy |
+3,389,155
| New | +$10.2M | 0.05% | 284 |
|